Insider Transactions in Q1 2024 at Vaxart, Inc. (VXRT)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 28
2024
|
Sean Tucker SVP, Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,902
-1.09%
|
$3,902
$1.3 P/Share
|
|
Mar 28
2024
|
James F. Cummings Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,292
-1.0%
|
$3,292
$1.3 P/Share
|
|
Mar 18
2024
|
Phillip E Lee Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
90,000
+27.12%
|
-
|
|
Mar 18
2024
|
Sean Tucker SVP, Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
90,000
+17.64%
|
-
|
|
Mar 18
2024
|
Edward B Berg SVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
90,000
+24.95%
|
-
|
|
Mar 18
2024
|
James F. Cummings Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
90,000
+21.42%
|
-
|
|
Mar 18
2024
|
Steven Lo President, Chief Exec Officer |
BUY
Grant, award, or other acquisition
|
Direct |
250,000
+50.0%
|
-
|
|
Feb 02
2024
|
Sean Tucker SVP, Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,220
-2.72%
|
$9,220
$1.2 P/Share
|
|
Feb 02
2024
|
Edward B Berg SVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
9,220
-4.85%
|
$9,220
$1.2 P/Share
|
|
Feb 02
2024
|
James F. Cummings Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,965
-3.21%
|
$7,965
$1.2 P/Share
|